OXYTETRACYCLINE Drug Patent Profile
✉ Email this page to a colleague
When do Oxytetracycline patents expire, and when can generic versions of Oxytetracycline launch?
Oxytetracycline is a drug marketed by Hikma, Impax Labs, Proter, and Purepac Pharm. and is included in four NDAs.
The generic ingredient in OXYTETRACYCLINE is oxytetracycline hydrochloride. There is one drug master file entry for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXYTETRACYCLINE?
- What are the global sales for OXYTETRACYCLINE?
- What is Average Wholesale Price for OXYTETRACYCLINE?
Summary for OXYTETRACYCLINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| DailyMed Link: | OXYTETRACYCLINE at DailyMed |
Recent Clinical Trials for OXYTETRACYCLINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Oslo | N/A |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for OXYTETRACYCLINE
Anatomical Therapeutic Chemical (ATC) Classes for OXYTETRACYCLINE
US Patents and Regulatory Information for OXYTETRACYCLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060770-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Purepac Pharm | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060634-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060760-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Proter | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060869-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
